Solvay stock: Solvay cuts 2026 outlook to EUR 720 million to EUR 740 million
Published on 10/20/2026 at 15:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSOutlook and trading facts
- Solvay lowered its 2026 underlying EBITDA outlook to EUR 720 million to EUR 740 million on October 19, 2026.
- Preliminary third-quarter underlying EBITDA reached EUR 173 million, while free cash flow was EUR 54 million.
- Solvay stock costs EUR 23.69 at Lang & Schwarz on October 20, 2026, 18.76 percent below its EUR 29.16 52-week high.
- Solvay plans to publish complete third-quarter results on November 4, 2026.
Solvay (ISIN BE0003470755) lowered its 2026 underlying EBITDA outlook to EUR 720 million to EUR 740 million on October 19, 2026, after a difficult preliminary third quarter. Reuters reported that the previous range was EUR 770 million to EUR 850 million. At Lang & Schwarz, the stock was trading at EUR 23.69 on October 20, 2026 at 3:16 p.m. CEST.
Third-quarter pressure cuts outlook
Solvay reported preliminary underlying net sales of EUR 1.03 billion and underlying EBITDA of EUR 173 million for the third quarter of 2026. Free cash flow to Solvay shareholders from continuing operations reached EUR 54 million in the same period.
The company said the Middle East conflict reduced underlying EBITDA by EUR 25 million during the third quarter. The continued shutdown of the peroxide plant at the Sadara complex in Jubail, Saudi Arabia, accounted for EUR 15 million of that impact.
Share price below yearly high
The Lang & Schwarz price of EUR 23.69 on October 20, 2026 stands 18.76 percent below the EUR 29.16 52-week high. The same dated market range places the low at EUR 22.58, leaving the stock EUR 1.11 above that level.
Solvay is listed on Euronext Brussels and Paris under the ticker SOLB. The company operates in chemicals, and its 2025 underlying net sales amounted to EUR 4.3 billion, according to the October 19 release.
November results date is set
Solvay plans to publish its complete third-quarter 2026 results on November 4, 2026. Until then, the preliminary figures and the revised full-year outlook leave cash generation as the key operating measure, with full-year free cash flow now expected between EUR 120 million and EUR 150 million.
Cash flow remains the key measure
The updated free cash flow outlook includes EUR 90 million of transformation expenses. For investors, the next report will clarify how much of the third-quarter disruption was temporary and how much affects the wider 2026 operating plan.
Solvay stock was trading at EUR 23.69 at Lang & Schwarz on October 20, 2026 at 3:16 p.m. CEST, with the share price 18.76 percent below its EUR 29.16 52-week high. The further course of trading is shown by the continuously updated real-time quote of Solvay stock.
Solvay market facts
- Company: Solvay S.A.
- ISIN: BE0003470755
- Ticker: SOLB
- Primary exchanges: Euronext Brussels and Paris
- Price Lang & Schwarz as of October 20, 2026, 3:16 p.m. CEST: EUR 23.69
- 52-week range as of October 20, 2026: EUR 22.58-EUR 29.16
- Sector / Industry: Chemicals / Diversified chemicals
Market context: Market report Euro Stoxx 50.
